Kenji Maeda
Kagoshima, 8908544, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 108 publications
Identification of a Novel Small Molecule Facilitating HIV Elimination by the "Shock-And-Kill" Approach.
Journal: Journal of medical virology
Published: April 10, 2026
Population Pharmacokinetic Modeling and Simulation to Support the Regulatory Submission of the Two-Injection Start Regimen with Aripiprazole Once-Monthly Long-Acting Injectable Intramuscular Administration in Japanese Patients with Schizophrenia or Bipolar I Disorder.
Journal: Journal of clinical pharmacology
Published: March 13, 2026
Hybrid immunity from bivalent vaccination and prior infection enhances humoral and innate protection against Omicron XBB.1.16 and EG.5.1.1 variants in Japan.
Journal: Frontiers in immunology
Published: February 09, 2026
Molecular signature of COVID-19 prior to its exacerbation by multi-omics survey.
Journal: PloS one
Published: January 14, 2026
Onnamides A and B Suppress Hepatitis B Virus Transcription by Inhibiting Viral Promoter Activity.
Journal: Marine drugs
Published: December 01, 2025
A novel hairless highly immunodeficient mice model optimized for in vivo imaging.
Journal: Laboratory animal research
Published: August 21, 2025
Synergistic Effect of Combination Treatment of Brexpiprazole and Nalmefene on Ethanol Intake in Rats.
Journal: Neuropsychopharmacology reports
Published: June 06, 2025
A high-throughput, fully automated competition assay to evaluate SARS-CoV-2 neutralizing responses and epitope specificity in clinical samples.
Journal: Scientific reports
Published: February 04, 2025
Population pharmacokinetics of brexpiprazole in Japanese healthy subjects and patients with schizophrenia.
Journal: Drug metabolism and pharmacokinetics
Published: October 29, 2024
Evaluating the Use of Sacran, a Polysaccharide Isolated from Aphanothece sacrum, as a Possible Microbicide for Preventing HIV-1 Infection.
Journal: Viruses
Published: July 25, 2024
Protection of Omicron Bivalent Vaccine, Previous Infection, and Their Induced Neutralizing Antibodies Against Symptomatic Infection With Omicron XBB.1.16 and EG.5.1.
Journal: Open forum infectious diseases
Published: June 06, 2024
Discovery of Potent DAG-Lactone Derivatives as HIV Latency Reversing Agents.
Journal: ACS infectious diseases
Published: May 21, 2024
Last Updated: 09/26/2026